Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 768515, 15 pages
http://dx.doi.org/10.1155/2014/768515
Research Article

Model for Vaccine Design by Prediction of B-Epitopes of IEDB Given Perturbations in Peptide Sequence, In Vivo Process, Experimental Techniques, and Source or Host Organisms

1Department of Organic Chemistry II, University of the Basque Country UPV/EHU, 48940 Bilbao, Spain
2Ikerbasque, Basque Foundation for Science, 48011 Bilbao, Spain
3Department of Microbiology and Parasitology, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain

Received 21 August 2013; Accepted 17 November 2013; Published 12 January 2014

Academic Editor: Darren R. Flower

Copyright © 2014 Humberto González-Díaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Peters, J. Sidney, P. Bourne et al., “The design and implementation of the immune epitope database and analysis resource,” Immunogenetics, vol. 57, no. 5, pp. 326–336, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Peters, J. Sidney, P. Bourne et al., “The immune epitope database and analysis resource: from vision to blueprint,” PLoS Biology, vol. 3, no. 3, p. e91, 2005. View at Google Scholar · View at Scopus
  3. P. Wang, A. A. Morgan, Q. Zhang, A. Sette, and B. Peters, “Automating document classification for the Immune Epitope Database,” BMC Bioinformatics, vol. 8, article 269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Sette, “The immune epitope database and analysis resource: from vision to blueprint,” Genome Informatics, vol. 15, no. 2, p. 299, 2004. View at Google Scholar · View at Scopus
  5. N. Salimi, W. Fleri, B. Peters, and A. Sette, “The immune epitope database: a historical retrospective of the first decade,” Immunology, vol. 137, no. 2, pp. 117–123, 2012. View at Publisher · View at Google Scholar
  6. Y. Kim, A. Sette, and B. Peters, “Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource,” Journal of Immunological Methods, vol. 374, no. 1-2, pp. 62–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Kim, J. Ponomarenko, Z. Zhu, D. Tamang et al., “Immune epitope database analysis resource,” Nucleic Acids Research, pp. W525–W530, 2012. View at Publisher · View at Google Scholar
  8. A. M. Helguera, R. D. Combes, M. P. Gonzalez, and M. N. D. S. Cordeiro, “Applications of 2D descriptors in drug design: a DRAGON tale,” Current Topics in Medicinal Chemistry, vol. 8, no. 18, pp. 1628–1655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. Casañola-Martín, Y. Marrero-Ponce, M. T. H. Khan et al., “Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays,” The European Journal of Medicinal Chemistry, vol. 42, no. 11-12, pp. 1370–1381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. I. V. Tetko, J. Gasteiger, R. Todeschini et al., “Virtual computational chemistry laboratory—design and description,” Journal of Computer-Aided Molecular Design, vol. 19, no. 6, pp. 453–463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. R. Katritzky, A. Oliferenko, A. Lomaka, and M. Karelson, “Six-membered cyclic ureas as HIV-1 protease inhibitors: a QSAR study based on CODESSA PRO approach,” Bioorganic and Medicinal Chemistry Letters, vol. 12, no. 23, pp. 3453–3457, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Katritzky, S. Perumal, R. Petrukhin, and E. Kleinpeter, “CODESSA-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities,” Journal of Chemical Information and Computer Sciences, vol. 41, no. 3, pp. 569–574, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Vilar, G. Cozza, and S. Moro, “Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery,” Current Topics in Medicinal Chemistry, vol. 8, no. 18, pp. 1555–1572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Marzaro, A. Chilin, A. Guiotto et al., “Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors,” The European Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 2185–2192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Vilar, E. Estrada, E. Uriarte, L. Santana, and Y. Gutierrez, “In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of tops-mode and 2D/3D connectivity indices. 2. Purine derivatives,” Journal of Chemical Information and Modeling, vol. 45, no. 2, pp. 502–514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Estrada, J. A. Quincoces, and G. Patlewicz, “Creating molecular diversity from antioxidants in Brazilian propolis. combination of TOPS-MODE QSAR and virtual structure generation,” Molecular Diversity, vol. 8, no. 1, pp. 21–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Estrada and H. González, “What are the limits of applicability for graph theoretic descriptors in QSPR/QSAR? modeling dipole moments of aromatic compounds with TOPS-MODE descriptors,” Journal of Chemical Information and Computer Sciences, vol. 43, no. 1, pp. 75–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Marrero-Ponce, J. A. Castillo-Garit, E. Olazabal et al., “Tomocomd-Cardd, a novel approach for computer-aided “rational” drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds,” Journal of Computer-Aided Molecular Design, vol. 18, no. 10, pp. 615–634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Marrero Ponce, R. Medina Marrero, E. A. Castro et al., “Protein quadratic indices of the “macromolecular pseudograph's α-carbon atom adjacency matrix”. 1. prediction of arc repressor alanine-mutant's stability,” Molecules, vol. 9, no. 12, pp. 1124–1147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. H. González-Díaz, F. Prado-Prado, and F. M. Ubeira, “Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach,” Current Topics in Medicinal Chemistry, vol. 8, no. 18, pp. 1676–1690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. García-Domenech, J. Gálvez, J. V. de Julián-Ortiz, and L. Pogliani, “Some new trends in chemical graph theory,” Chemical Reviews, vol. 108, no. 3, pp. 1127–1169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Estrada and E. Uriarte, “Recent advances on the role of topological indices in drug discovery research,” Current Medicinal Chemistry, vol. 8, no. 13, pp. 1573–1588, 2001. View at Google Scholar · View at Scopus
  23. R. Todeschini and V. Consonni, Handbook of Molecular Descriptors, Wiley-VCH, Weinheim, Germany, 2008. View at Publisher · View at Google Scholar
  24. E. Estrada, E. J. Delgado, J. B. Alderete, and G. A. Jaña, “Quantum-connectivity descriptors in modeling solubility of environmentally important organic compounds,” Journal of Computational Chemistry, vol. 25, no. 14, pp. 1787–1796, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Besalu, X. Girones, L. Amat, and R. Carbo-Dorca, “Molecular quantum similarity and the fundamentals of QSAR,” Accounts of Chemical Research, vol. 35, no. 5, pp. 289–295, 2002. View at Publisher · View at Google Scholar
  26. D. A. Rincón, M. N. D. S. Cordeiro, and R. A. Mosquera, “On the electronic structure of cocaine and its metabolites,” Journal of Physical Chemistry A, vol. 113, no. 50, pp. 13937–13942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Mandado, M. J. González-Moa, and R. A. Mosquera, “Chemical graph theory and n-center electron delocalization indices: a study on polycyclic aromatic hydrocarbons,” Journal of Computational Chemistry, vol. 28, no. 10, pp. 1625–1633, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Hill and P. Lewicki, STATISTICS: Methods and Applications: A Comprehensive Reference for Science, Industry and Data Mining, StatSoft, Tulsa, Okla, USA, 2006.
  29. E. Frank, M. Hall, L. Trigg, G. Holmes, and I. H. Witten, “Data mining in bioinformatics using Weka,” Bioinformatics, vol. 20, no. 15, pp. 2479–2481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Patlewicz, N. Ball, E. D. Booth, E. Hulzebos, E. Zvinavashe, and C. Hennes, “Use of category approaches, read-across and (Q)SAR: general considerations,” Regulatory Toxicology and Pharmacology, vol. 67, no. 1, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  31. D. W. Roberts and G. Y. Patlewicz, “Updating the skin sensitization in vitro data assessment paradigm in 2009—a chemistry and QSAR perspective,” Journal of Applied Toxicology, vol. 30, no. 3, pp. 286–288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. W. Roberts and G. Y. Patlewicz, “Nonanimal alternatives for skin sensitization: letter to the editor,” Toxicological Sciences, vol. 106, no. 2, pp. 572–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Estrada, G. Patlewicz, and Y. Gutierrez, “From knowledge generation to knowledge archive. a general strategy using TOPS-MODE with DEREK to formulate new alerts for skin sensitization,” Journal of Chemical Information and Computer Sciences, vol. 44, no. 2, pp. 688–698, 2004. View at Google Scholar · View at Scopus
  34. G. F. Gerberick, C. A. Ryan, P. S. Kern et al., “A chemical dataset for evaluation of alternative approaches to skin-sensitization testing,” Contact Dermatitis, vol. 50, no. 5, pp. 274–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Y. Patlewicz, D. A. Basketter, C. K. Smith Pease et al., “Further evaluation of quantitative structure–activity relationship models for the prediction of the skin sensitization potency of selected fragrance allergens,” Contact Dermatitis, vol. 50, no. 2, pp. 91–97, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Estrada, G. Patlewicz, M. Chamberlain, D. Basketter, and S. Larbey, “Computer-aided knowledge generation for understanding skin sensitization mechanisms: the TOPS-MODE approach,” Chemical Research in Toxicology, vol. 16, no. 10, pp. 1226–1235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Patlewicz, R. Rodford, and J. D. Walker, “Quantitative structure-activity relationships for predicting skin and eye irritation,” Environmental Toxicology and Chemistry, vol. 22, no. 8, pp. 1862–1869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Y. Patlewicz, R. A. Rodford, G. Ellis, and M. D. Barratt, “A QSAR model for the eye irritation of cationic surfactants,” Toxicology In Vitro, vol. 14, no. 1, pp. 79–84, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Tenorio-Borroto, C. G. Penuelas Rivas, J. C. Vasquez Chagoyan, N. Castanedo, F. J. Prado-Prado, and X. Garcia-Mera, “ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen,” Bioorganic & Medicinal Chemistry, vol. 20, no. 20, pp. 6181–6194, 2012. View at Google Scholar
  40. D. R. Flower, H. McSparron, M. J. Blythe et al., “Computational vaccinology: quantitative approaches,” Novartis Foundation Symposium, vol. 254, pp. 102–120, 2003. View at Google Scholar · View at Scopus
  41. I. A. Doytchinova, P. Guan, and D. R. Flower, “Quantitative structure-activity relationships and the prediction of MHC supermotifs,” Methods, vol. 34, no. 4, pp. 444–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Xiao and M. R. Segal, “Prediction of genomewide conserved epitope profiles of HIV-1: classifier choice and peptide representation,” Statistical Applications in Genetics and Molecular Biology, vol. 4, no. 1, article 25, 2005. View at Google Scholar · View at Scopus
  43. T. Fagerberg, V. Zoete, S. Viatte, P. Baumgaertner, P. M. Alves, P. Romero et al., “Prediction of cross-recognition of peptide-HLA A2 by melan-a-specific cytotoxic T lymphocytes using three-dimensional quantitative structure-activity relationships,” PLoS ONE, vol. 8, no. 7, Article ID e65590, 2013. View at Publisher · View at Google Scholar
  44. D. Barh, A. N. Misra, A. Kumar, and A. Vasco, “A novel strategy of epitope design in Neisseria gonorrhoeae,” Bioinformation, vol. 5, no. 2, pp. 77–82, 2010. View at Publisher · View at Google Scholar
  45. J. Bi, R. Song, H. Yang et al., “Stepwise identification of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus type 1 genome boosted by a steprank scheme,” Biopolymers, vol. 96, no. 3, pp. 328–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. R. D. Bremel and E. J. Homan, “An integrated approach to epitope analysis II: a system for proteomic-scale prediction of immunological characteristics,” Immunome Research, vol. 6, no. 1, article 8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. C. M. Diez-Rivero, B. Chenlo, P. Zuluaga, and P. A. Reche, “Quantitative modeling of peptide binding to TAP using support vector machine,” Proteins, vol. 78, no. 1, pp. 63–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Martínez-Naves, E. M. Lafuente, and P. A. Reche, “Recognition of the ligand-type specificity of classical and non-classical MHC I proteins,” FEBS Letters, vol. 585, no. 21, pp. 3478–3484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Bhasin, E. L. Reinherz, and P. A. Reche, “Recognition and classification of histones using support vector machine,” Journal of Computational Biology, vol. 13, no. 1, pp. 102–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. P. A. Reche and E. L. Reinherz, “PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands,” Nucleic Acids Research, vol. 33, no. 2, pp. W138–W142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. E. M. Lafuente and P. A. Reche, “Prediction of MHC-peptide binding: a systematic and comprehensive overview,” Current Pharmaceutical Design, vol. 15, no. 28, pp. 3209–3220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Gaulton, L. J. Bellis, A. P. Bento et al. et al., “A large-scale bioactivity database for drug discovery,” Nucleic Acids Research, pp. D1100–D1107, 2012. View at Google Scholar
  53. W. H. Cropper, Great Physicists: The Life and Times of Leading Physicists from Galileo to Hawking, Oxford University Press, New York, NY, USA, 2004.
  54. E. L. Bouzarth, A. Brooks, R. Camassa et al., “Epicyclic orbits in a viscous fluid about a precessing rod: theory and experiments at the micro-and macro-scales,” Physical Review E, vol. 76, no. 1, part 2, Article ID 016313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Laberge, “Intrinsic protein electric fields: basic non-covalent interactions and relationship to protein-induced Stark effects,” Biochimica et Biophysica Acta, vol. 1386, no. 2, pp. 305–330, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. F. M. Fernandez and J. A. Morales, “Perturbation theory without wave functions for the Zeeman effect in hydrogen,” Physical Review A, vol. 46, no. 1, pp. 318–326, 1992. View at Publisher · View at Google Scholar · View at Scopus
  57. B. D. Marshall and W. G. Chapman, “Thermodynamic perturbation theory for associating fluids with small bond angles: effects of steric hindrance, ring formation, and double bonding,” Physical Reiew E, vol. 87, no. 5, Article ID 052307, 12 pages, 2013. View at Publisher · View at Google Scholar
  58. H. Gonzalez-Diaz, S. Arrasate, A. Gomez-San Juan et al., “New theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry,” Current Topics in Medicinal Chemistry, 2013. View at Google Scholar
  59. H. Gonzalez-Diaz, S. Arrasate, N. Sotomayor et al., “MIANN models in medicinal, physical and organic chemistry,” Current Topics in Medicinal Chemistry, vol. 13, no. 5, pp. 619–641, 2013. View at Publisher · View at Google Scholar
  60. G. E. P. Box and G. M. Jenkins, Time Series Analysis: Forecasting and Control, Holden-Day, San Francisco, Calif, USA, 1970.
  61. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. Cordeiro, “Unified multi-target approach for the rational in silico design of anti-bladder cancer agents,” Anti-Cancer Agents in Medicial Chemistry, vol. 13, no. 5, pp. 791–800, 2013. View at Publisher · View at Google Scholar
  62. A. Speck-Planche, V. V. Kleandrova, and M. N. Cordeiro, “New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs,” The European Journal of Pharmaceutical Sciences, vol. 48, no. 4-5, pp. 812–818, 2013. View at Publisher · View at Google Scholar
  63. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. Cordeiro, “Multi-target inhibitors for proteins associated with Alzheimer: in silico discovery using fragment-based descriptors,” Current Alzheimer Research, vol. 10, no. 2, pp. 117–124, 2013. View at Publisher · View at Google Scholar
  64. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. Cordeiro, “In silico discovery and virtual screening of multi-target inhibitors for proteins in Mycobacterium tuberculosis,” Combinatorial Chemistry & High Throughput Screening, vol. 15, no. 8, pp. 666–673, 2012. View at Publisher · View at Google Scholar
  65. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. D. S. Cordeiro, “Chemoinformatics in anti-cancer chemotherapy: multi-target QSAR model for the in silico discovery of anti-breast cancer agents,” The European Journal of Pharmaceutical Sciences, vol. 47, no. 1, pp. 273–279, 2012. View at Publisher · View at Google Scholar · View at Scopus